January 2024
189 articles-
Jan 30 · 23:14Biotechnology Daily
AstraZeneca's failed cancer drug gets new lease on life thanks to positive kidney disease data
-
Jan 30 · 23:12Biotechnology Daily
CooperSurgical doubles back with slimmed-down deal for Cook Medical's OB-GYN assets
-
Jan 30 · 23:10Biotechnology Daily
Locanabio seeks new homes for genetic medicines as it winds down operations
-
Jan 30 · 23:03Biotechnology Daily
Researchers cover bases with 2 different gene editing modalities to treat rare disease
-
Jan 30 · 23:02Bio Business News
Siemens Healthineers reports 300 layoffs amid rumors of a possible diagnostics unit sell-off
-
Jan 30 · 23:01Bio Business News
BMS snags another ADC with modest $100M Orum deal
-
Jan 30 · 22:58Bio Business News
Lexeo drops share price at last minute in attempt to raise $100M IPO
-
Jan 30 · 22:56Bio Business News
Kronos cuts 19% of staff to make way for phase 1/2 solid tumor drug
-
Jan 29 · 23:39Biotechnology Daily
Blood-clot buster Inari snatches up limb-saving implant maker LimFlow for $415M
-
Jan 29 · 23:36Biotechnology Daily
‘Potential game changer’: Gonorrhea antibiotic compares to standard of care in phase 3
-
Jan 29 · 23:34Biotechnology Daily
Kymera cuts lymphoma med that performed as expected in phase 1
-
Jan 29 · 23:32Biotechnology Daily
Medeor cell therapy helps kidney transplant patients taper off immunosuppressant meds
-
Jan 29 · 23:29Bio Business News
Lilly's obesity portfolio in 'all-of-the-above mode'
-
Jan 29 · 23:28Bio Business News
With first microbiome drug approved, Seres slims R&D efforts and workforce
-
Jan 29 · 23:26Bio Business News
Stéphane Bancel suggests Moderna could be open to out-licensing if sales struggle
-
Jan 29 · 23:25Bio Business News
Resolian, the CRO formerly known as Alliance, makes move into China with Denali acquisition
-
Jan 29 · 21:11Market Watch
McGrath RentCorp Shares Touch 52-Week High on WillScot Deal
-
Jan 29 · 00:28Biotechnology Daily
FDA places Nurix's cancer drug on partial hold while manufacturing process upgraded
-
Jan 29 · 00:27Biotechnology Daily
Prelude thinks SMARCA with AbCellera deal while chopping pair of phase 1 candidates
-
Jan 29 · 00:25Biotechnology Daily
Flagship launches formal AI initiative in Pioneering Intelligence
-
Jan 29 · 00:24Biotechnology Daily
Tonix halts major depression disorder drug after phase 2 failure
-
Jan 29 · 00:23Bio Business News
C4 Therapeutics discontinues cancer program, waits for Betta payment
-
Jan 29 · 00:21Bio Business News
Rani and Sangamo jettison staff, offices and assets to keep businesses afloat next year
-
Jan 29 · 00:20Bio Business News
3D spatial omics profiler Stellaromics scores $25M series A